A
$ Value
$0
Shares
45,195
Price
$0
Filed
Mar 3
Insider
Name
DeSimone John
Title
Chief Financial Officer
CIK
0001463405
Roles
Officer
Transaction Details
Transaction Date
2026-02-25
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
45,195
Footnotes
This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed. | Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date.
Filing Info
Other Insiders at HLF (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| JOHNSON MICHAEL | — | — | 2026-02-25 |
|
LEVY ROBERT
President
|
— | — | 2026-02-25 |
|
DeSimone John
Chief Financial Officer
|
— | — | 2026-02-16 |
|
Lamberti Frank
Chief Commercial Officer
|
— | — | 2026-02-25 |
|
Wang Henry C
Chief Legal Officer
|
— | — | 2026-02-25 |
|
Gratziani Stephan Paulo
Chief Executive Officer
|
— | — | 2026-02-25 |
|
Hicks Troy
Chief Operating Officer
|
— | — | 2026-02-25 |